Forum menu
Were all the large trials that Kendricks has access to flawed then, how come they showed virtually no benefit to mortality rates from statins ?
Just as flawed as the large trials that did show a benefit....
Less that a quid a month for generic statins....
Less that a quid a month for generic statins....
Give it a few years, the latest wonder drug for lowering cholesterol will be touted instead. In fact, it's already begun in some instances - look up PCSK9 inhibitors.
Mulv, NICE will decide whether they are beneficial enough to be prescribed on the NHS and under what circumstances. And if the decision is in the "give it a few years" timescale, they'll be off patent too, so relatively cheap. (Although because PCSK9 inhibitors are biologicals, bioequivalence will be harder to prove)
Drugs do come off-patent fairly quickly. Viagra, for instance, has much cheaper competitors with the same active ingredient now that Pfizer's patent has expired.